Uncertainty over value of beta-blockers

Beta-blockers have no mortality benefit in patients post myocardial infarction (MI), say researchers involved in two studies published in The American Journal of Medicine.

In one study, beta-blockers were found to increase the risk of heart failure post MI and the researchers suggest current guidelines be reviewed.

“In patients undergoing contemporary treatment, our data support the short-term [30 days] use of beta-blockers to reduce recurrent heart attacks and